Metabolic phenotyping for monitoring ovarian cancer patients
Authors:
Open Access
- 21 March 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 23334
Abstract
Epithelial ovarian cancer (EOC) is the most deadly of the gynecological cancers. New approaches and better tools for monitoring treatment efficacy and disease progression of EOC are required. In this study, metabolomics using rapid resolution liquid chromatography mass spectrometry was applied to a systematic investigation of metabolic changes in response to advanced EOC, surgery and recurrence. The results revealed considerable metabolic differences between groups. Moreover, 37, 30, and 26 metabolites were identified as potential biomarkers for primary, surgical and recurrent EOC, respectively. Primary EOC was characterized by abnormal lipid metabolism and energy disorders. Oxidative stress and surgical efficacy were clear in the post-operative EOC patients. Recurrent EOC patients showed increased amino acid and lipid metabolism compared with primary EOC patients. After cytoreductive surgery, eight metabolites (e.g. l-kynurenine, retinol, hydroxyphenyllactic acid, 2-octenoic acid) corrected towards levels of the control group, and four (e.g. hydroxyphenyllactic acid, 2-octenoic acid) went back again to primary EOC levels after disease relapse. In conclusion, this study delineated metabolic changes in response to advanced EOC, surgery and recurrence, and identified biomarkers that could facilitate both understanding and monitoring of EOC development and progression.Keywords
This publication has 39 references indexed in Scilit:
- Platinum-Sensitive Recurrence in Ovarian Cancer: The Role of Tumor MicroenvironmentFrontiers in Oncology, 2013
- Human serum metabolic profiles are age dependentAging Cell, 2012
- Therapeutic strategies in epithelial ovarian cancerJournal of Experimental & Clinical Cancer Research, 2012
- Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platformActa Oncologica, 2012
- Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?Open Biology, 2012
- CAMERA: An Integrated Strategy for Compound Spectra Extraction and Annotation of Liquid Chromatography/Mass Spectrometry Data SetsAnalytical Chemistry, 2011
- Identification of Metabolites in the Normal Ovary and Their Transformation in Primary and Metastatic Ovarian CancerPLOS ONE, 2011
- Metabolomic Characterization of Ovarian Epithelial Carcinomas by HRMAS-NMR SpectroscopyJournal of Oncology, 2011
- An overview of randomization techniques: An unbiased assessment of outcome in clinical researchJournal of Human Reproductive Sciences, 2011
- XCMS: Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and IdentificationAnalytical Chemistry, 2006